← Leaderboards
Lloyd C Trotman
State University New York Stony Brook
$10,047,682
Attributed
$12,533,642
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,533,642 · 9
By mechanism
R01$9,118,602 · 3
P30$2,992,554 · 5
T32$422,486 · 1
Top collaborators
- Martin Kaczocha5 shared
- Iwao Ojima5 shared
- Robert C. Rizzo5 shared
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Lucia Yang$135,812
- Mirjana Maletic-Savatic$7,420,032
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularNeoplasm MetastasisSamplingIn VivoTumorMalignant Neoplasm Of ProstateSignal TransductionProstateMetastatic Prostate CancerMalignant NeoplasmsCellsAnimalsProgramsFundingGenetically Engineered MouseTechnologyPositioning AttributeBaseResistanceMouse ModelIn VitroResponseCancer BiologyEvent
Grant awards (31)
Metastasis of PTEN Mutant Prostate Cancer$1,105,348
R01 · FY2025 · CA · contact PI
Animal & Tissue Imaging Shared Resource$455,147
P30 · FY2025 · CA · contact PI
Cancer Research Training and Education Coordination$85,121
P30 · FY2025 · CA · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$629,362
R01 · FY2024 · CA
Metastasis of PTEN Mutant Prostate Cancer$525,040
R01 · FY2024 · CA · contact PI
Animal & Tissue Imaging Shared Resource$444,876
P30 · FY2024 · CA · contact PI
Cancer Research Training and Education Coordination$93,354
P30 · FY2024 · CA · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$654,000
R01 · FY2023 · CA
Metastasis of PTEN Mutant Prostate Cancer$541,620
R01 · FY2023 · CA · contact PI
Animal & Tissue Imaging Shared Resource$455,147
P30 · FY2023 · CA · contact PI
Cancer Research Training and Education Coordination$85,121
P30 · FY2023 · CA · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$658,627
R01 · FY2022 · CA
Metastasis of PTEN Mutant Prostate Cancer$529,446
R01 · FY2022 · CA · contact PI
Animal & Tissue Imaging Shared Resource$455,147
P30 · FY2022 · CA · contact PI
Cancer Research Training and Education Coordination$85,121
P30 · FY2022 · CA · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$676,650
R01 · FY2021 · CA
Animal & Tissue Imaging Shared Resource$455,147
P30 · FY2021 · CA · contact PI
Cancer Research Training and Education Coordination$85,121
P30 · FY2021 · CA · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$695,974
R01 · FY2020 · CA
Animal and Tissue Imaging Shared Resource$293,252
P30 · FY2020 · CA · contact PI
CSHL Cancer Gene Discovery and Cancer Biology Postdoctoral Research Training Program$214,339
T32 · FY2020 · CA · contact PI
CSHL Cancer Gene Discovery and Cancer Biology Postdoctoral Research Training Program$208,147
T32 · FY2019 · CA · contact PI
Mechanism and treatment of PTEN mutant prostate tumorigenesis$398,400
R01 · FY2018 · CA · contact PI
Mechanism and treatment of PTEN mutant prostate tumorigenesis$398,400
R01 · FY2017 · CA · contact PI
Mechanism and treatment of PTEN mutant prostate tumorigenesis$398,400
R01 · FY2016 · CA · contact PI
Mechanism and treatment of PTEN mutant prostate tumorigenesis$398,400
R01 · FY2015 · CA · contact PI
Mechanism and treatment of PTEN mutant prostate tumorigenesis$392,175
R01 · FY2014 · CA · contact PI
Mechanisms and Treatment of PTEN Mutant Prostate Tumorigenesis$286,069
R01 · FY2013 · CA · contact PI
Mechanisms and Treatment of PTEN Mutant Prostate Tumorigenesis$301,376
R01 · FY2012 · CA · contact PI
Mechanisms and Treatment of PTEN Mutant Prostate Tumorigenesis$240,475
R01 · FY2011 · CA · contact PI
Mechanisms and Treatment of PTEN Mutant Prostate Tumorigenesis$288,840
R01 · FY2010 · CA · contact PI